Insights

Growing Funding Mediar Therapeutics has secured substantial funding, including an $85 million Series A and a $76 million Series B, indicating strong investor confidence and potential for expanding research collaborations and clinical development partnerships.

Innovation Focus The company's pioneering approach targeting myofibroblasts in fibrosis with novel biomarkers and precision medicine strategies presents opportunities to collaborate with pharmaceutical companies seeking advanced anti-fibrotic therapies.

Industry Positioning As a biotech with recent high-profile investments from major venture funds and engagement with pharma giants like Novartis and Pfizer, Mediar is well-positioned for strategic alliances and licensing deals in fibrosis treatment space.

Market Expansion Recent funding and executive appointments suggest Mediar is actively expanding its operations and leadership to accelerate product development and market entry, creating opportunities for service providers and strategic partners.

Collaborative Potential With a focus on precision medicine and novel targets, Mediar offers a compelling partnership opportunity for companies specializing in biomarker development, diagnostic tools, and personalized medicine solutions aimed at fibrosis.

Mediar Therapeutics Tech Stack

Mediar Therapeutics uses 8 technology products and services including SAP, MySQL, Shopify, and more. Explore Mediar Therapeutics's tech stack below.

SAP

Customer Relationship Management

MySQL

Database

Shopify

E-commerce

JSON-LD

Javascript Frameworks

Retina graphics

Javascript Graphics

Priority Hints

Performance

Adobe Creative Suite

Visualisation Software

Popup Maker

Web Platform Extensions

Mediar Therapeutics Email Formats	Example	Percentage
First@mediartx.com	John@mediartx.com	37%
First.Last@mediartx.com	John.Doe@mediartx.com	13%
First@mediartx.com	John@mediartx.com	37%
First.Last@mediartx.com	John.Doe@mediartx.com	13%

Mediar Therapeutics Email Formats

Example

Percentage

First@mediartx.com

John@mediartx.com

37%

First.Last@mediartx.com

John.Doe@mediartx.com

13%

First@mediartx.com

John@mediartx.com

37%

First.Last@mediartx.com

John.Doe@mediartx.com

13%

Frequently Asked Questions

Where is Mediar Therapeutics's headquarters located?

Mediar Therapeutics's main headquarters is located at 20 Overland Street Boston, Massachusetts 02215 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Mediar Therapeutics's official website and social media links?

Mediar Therapeutics's official website is mediartx.com and has social profiles on LinkedIn Crunchbase.

What is Mediar Therapeutics's SIC code NAICS code?

Mediar Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mediar Therapeutics have currently?

As of February 2026, Mediar Therapeutics has approximately 54 employees across 2 continents, including North AmericaEurope. Key team members include Chief Scientific Officer: P. Y.Chief Medical Officer: J. B.Co-Founder & Sab: D. L.. Explore Mediar Therapeutics's employee directory with LeadIQ.

What industry does Mediar Therapeutics belong to?

Mediar Therapeutics operates in the Biotechnology Research industry.

What technology does Mediar Therapeutics use?

Mediar Therapeutics's tech stack includes SAPMySQLShopifyJSON-LDRetina graphicsPriority HintsAdobe Creative SuitePopup Maker.

What is Mediar Therapeutics's email format?

Mediar Therapeutics's email format typically follows the pattern of First@mediartx.com. Find more Mediar Therapeutics email formats with LeadIQ.

How much funding has Mediar Therapeutics raised to date?

As of February 2026, Mediar Therapeutics has raised $85M in funding. The last funding round occurred on Mar 15, 2023 for $85M.

When was Mediar Therapeutics founded?

Mediar Therapeutics was founded in 2019.

Mediar Therapeutics

Q: What is Mediar Therapeutics's official website and social media links?

Mediar Therapeutics's official website is mediartx.com. Mediar Therapeutics has social profiles on LinkedIn.

Q: How many employees does Mediar Therapeutics have currently?

Mediar Therapeutics has approximately 54 employees.

Q: What technology does Mediar Therapeutics use?

Mediar Therapeutics's tech stack includes Microsoft, Google Tag Manager, Gravity Forms, Google Fonts API, Stimulus.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure.

Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach.

For more information, contact info@mediartx.com

Insights

Similar companies to Mediar Therapeutics

Fusion Antibodies

Horizon Discovery

Abzena

Affimed

Aptamer Group